Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 29.38B | 26.83B | 22.53B | 21.90B | 19.38B | 12.00B |
Gross Profit | 10.55B | 8.77B | 5.44B | 3.85B | 4.04B | 2.84B |
EBITDA | 1.01B | 1.19B | -1.67B | -5.02B | -3.95B | -1.07B |
Net Income | 220.34M | -1.35B | -4.82B | -7.51B | -6.81B | -3.01B |
Balance Sheet | ||||||
Total Assets | 38.79B | 32.70B | 33.16B | 41.83B | 52.05B | 23.87B |
Cash, Cash Equivalents and Short-Term Investments | 22.29B | 16.54B | 15.04B | 19.56B | 30.22B | 12.76B |
Total Debt | 9.82B | 5.05B | 7.64B | 15.54B | 19.22B | 8.59B |
Total Liabilities | 24.64B | 18.59B | 18.75B | 26.59B | 30.34B | 16.08B |
Stockholders Equity | 14.16B | 14.11B | 14.39B | 15.24B | 21.70B | 7.60B |
Cash Flow | ||||||
Free Cash Flow | 3.29B | 4.26B | -1.06B | -6.65B | -6.33B | -1.49B |
Operating Cash Flow | 3.29B | 6.01B | 266.62M | -3.91B | -2.65B | 753.10M |
Investing Cash Flow | -7.19B | -138.09M | 1.76B | 10.61B | -24.58B | -8.91B |
Financing Cash Flow | 4.30B | -2.83B | -5.07B | -4.35B | 30.39B | 8.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | HK$714.77B | 20.60 | 24.23% | 1.69% | 2.48% | 19.49% | |
76 Outperform | $5.18B | 9.05 | 17.91% | 3.19% | 4.02% | -23.98% | |
71 Outperform | $47.30B | 24.86 | 7.25% | 0.40% | 15.08% | 84.20% | |
71 Outperform | HK$89.97B | 389.75 | 1.58% | ― | 22.43% | ― | |
67 Neutral | HK$38.13B | 25.70 | 57.06% | 0.51% | 51.87% | 4031.49% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
46 Neutral | HK$2.14B | ― | -27.26% | ― | -17.65% | 48.05% |